473 related articles for article (PubMed ID: 17639584)
1. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
Yan Y; Park SS; Janz S; Eckhardt LA
Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
[TBL] [Abstract][Full Text] [Related]
2. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
[TBL] [Abstract][Full Text] [Related]
3. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Wang J; Boxer LM
J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
[TBL] [Abstract][Full Text] [Related]
4. The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesis.
Ghazzaui N; Saintamand A; Issaoui H; Vincent-Fabert C; Denizot Y
Oncotarget; 2017 Jan; 8(4):7059-7067. PubMed ID: 27729620
[TBL] [Abstract][Full Text] [Related]
5. The IgH 3' regulatory region and its implication in lymphomagenesis.
Vincent-Fabert C; Fiancette R; Cogné M; Pinaud E; Denizot Y
Eur J Immunol; 2010 Dec; 40(12):3306-11. PubMed ID: 21080376
[TBL] [Abstract][Full Text] [Related]
6. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
7. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
[TBL] [Abstract][Full Text] [Related]
8. Mouse Models of
Ferrad M; Ghazzaui N; Issaoui H; Cook-Moreau J; Denizot Y
Front Immunol; 2020; 11():1564. PubMed ID: 32793219
[TBL] [Abstract][Full Text] [Related]
9. Eμ and 3'RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomas.
Ghazzaui N; Issaoui H; Ferrad M; Carrion C; Cook-Moreau J; Denizot Y; Boyer F
Blood Adv; 2020 Jan; 4(1):28-39. PubMed ID: 31899800
[TBL] [Abstract][Full Text] [Related]
10. Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3' regulatory region.
Gostissa M; Yan CT; Bianco JM; Cogné M; Pinaud E; Alt FW
Nature; 2009 Dec; 462(7274):803-7. PubMed ID: 20010689
[TBL] [Abstract][Full Text] [Related]
11. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
12. The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype.
Truffinet V; Pinaud E; Cogné N; Petit B; Guglielmi L; Cogné M; Denizot Y
J Immunol; 2007 Nov; 179(9):6033-42. PubMed ID: 17947677
[TBL] [Abstract][Full Text] [Related]
13. Sequential activation and distinct functions for distal and proximal modules within the IgH 3' regulatory region.
Garot A; Marquet M; Saintamand A; Bender S; Le Noir S; Rouaud P; Carrion C; Oruc Z; Bébin AG; Moreau J; Lebrigand K; Denizot Y; Alt FW; Cogné M; Pinaud E
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1618-23. PubMed ID: 26831080
[TBL] [Abstract][Full Text] [Related]
14. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
15. Functional anatomy of the immunoglobulin heavy chain 3΄ super-enhancer needs not only core enhancer elements but also their unique DNA context.
Le Noir S; Boyer F; Lecardeur S; Brousse M; Oruc Z; Cook-Moreau J; Denizot Y; Cogné M
Nucleic Acids Res; 2017 Jun; 45(10):5829-5837. PubMed ID: 28369649
[TBL] [Abstract][Full Text] [Related]
16. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
17. The IgH 3' regulatory region influences lymphomagenesis in Igλ-Myc mice.
Saad F; Saintamand A; Cogné M; Denizot Y
Oncotarget; 2015 Aug; 6(24):20302-11. PubMed ID: 25980500
[TBL] [Abstract][Full Text] [Related]
18. The IgH locus 3' regulatory region: pulling the strings from behind.
Pinaud E; Marquet M; Fiancette R; Péron S; Vincent-Fabert C; Denizot Y; Cogné M
Adv Immunol; 2011; 110():27-70. PubMed ID: 21762815
[TBL] [Abstract][Full Text] [Related]
19. The IgH 3' regulatory region governs μ chain transcription in mature B lymphocytes and the B cell fate.
Saintamand A; Rouaud P; Garot A; Saad F; Carrion C; Oblet C; Cogné M; Pinaud E; Denizot Y
Oncotarget; 2015 Mar; 6(7):4845-52. PubMed ID: 25742787
[TBL] [Abstract][Full Text] [Related]
20. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
